The Board of Directors of
SynAct has on
The request states that the following persons are proposed as new members of the Board of Directors:
-
-
-
- Jeppe Øvlesen
In addition, it is stated that
The request has been presented by the following larger shareholders:
TJ Biotech Invest ApS Goodwind Holding GmbH Thomas Ringberg
and some other shareholders where no individual shareholder holds more than 0.38%. Main owner of
Since the request has been made by shareholders who jointly own more than ten percent, the formal requirement is fulfilled for a request for notice of an EGM. The Board of Directors will hence within two weeks from
For further information about SynAct Pharma AB, please contact:
Chairman of the Board,
Email: investorrelations@synactpharma.com
© Modular Finance, source